Monday's top analyst upgrades and downgrades included Carvana, Cloudflare, Comcast, ConocoPhillips, Constellation Brands, Exxon Mobil, Eli Lilly, SoFi Technologies and Starbucks.
Despite further upside expected for Merck (MRK) on account of its much-anticipated COVID-19 pill, the analysts at J.P
SEATTLE, Oct. 06, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights' analysis, the global GLP-1 receptor agonist market is estimated to be valued at US$ 12,720.6...
Leading pharma group AbbVie (NYSE:ABBV) issued robust Q2 metrics in late July. However, since then, ABBV stock has been volatile. Between July 30 and Aug. 10, the shares initially...
After the US paused distribution of Eli Lilly And Co's COVID-19 antibody therapies in June, the pharmaceutical company says those therapies are once again being distributed.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Buy | Strong Buy | Buy | Buy |
| Technical Indicators | Buy | Neutral | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Neutral | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 42.53 | 42.83 | 42.42 | +0.06 | +0.14% | 766.70K | Toronto | |||
| 23.07 | 23.45 | 23.05 | +0.13 | +0.57% | 2.63M | Toronto | |||
| 18.20 | 18.20 | 18.07 | +0.14 | +0.78% | 2.72K | Toronto | |||
| 0.085 | 0.00 | 0.00 | 0.0000 | 0.00% | 4.60K | TSXV | |||
| 0.98 | 1.06 | 0.00 | -0.11 | -10.09% | 1.13M | Toronto | |||
| 73.10 | 74.19 | 72.84 | -0.49 | -0.67% | 88.13K | Toronto | |||
| 4.81 | 4.86 | 4.69 | +0.170 | +3.66% | 2.63M | Toronto | |||
| 6.28 | 6.47 | 6.24 | -0.06 | -0.95% | 4.05M | Toronto | |||
| 44.67 | 45.02 | 44.58 | -0.13 | -0.29% | 86.81K | Toronto | |||
| 15.11 | 15.42 | 13.57 | +2.060 | +15.79% | 866.10K | NEO | |||
| 32.75 | 33.14 | 32.72 | -0.20 | -0.61% | 435.05K | Toronto | |||
| 27.96 | 28.11 | 27.91 | +0.06 | +0.22% | 1.48M | Toronto | |||
| 167.63 | 168.00 | 166.16 | +1.07 | +0.64% | 206.03K | Toronto | |||
| 47.67 | 48.09 | 47.33 | -0.18 | -0.38% | 1.11M | Toronto | |||
| 14.43 | 14.90 | 14.41 | -0.12 | -0.82% | 5.21M | Toronto |
Eli Lilly and Company is a drug manufacturing company. The Company discover, develop, manufacture, and market products in a human pharmaceutical product segment. The Company’s products include Diabetes and other endocrinology products, including Baqsimi, Basaglar, Forteo, Humalog, Humatrope, Humulin, Jardiance, Trajenta and Trulicity. Its Immunology products include Olumiant and Taltz. Its Neuroscience products include Cymbalta, Emgality, Reyvow, Strattera and Zyprexa. Its Oncology products include Alimta, Cyramza, Erbitux and Verzenio. Other product includes Cialis, for the tratment of erectile dysfunction and benign prostatic hyperplasia. The Company manufacture and distribute its products through facilities in the United States, Puerto Rico, and 8 other countries. Its products are sold in approximately 120 countries.